EpigenCare is a personalized skincare platform that uses an at-home test to develop "epigenetic profiles and skincare recommendations for the consumer."
As part of Johnson & Johnson’s Digital QuickFire Challenge, EpigenCare was named one of the winners. EpigenCare's direct-to-consumer test kits are set to launch later in the year and will be useful for suggesting care solutions based on factors like aging, elasticity, moisture and pigmentation.
The non-invasive kit is designed to collect a consumer's DNA from the skin—rather than another source, such as saliva—and help to measure whether or not a skincare product is delivering the desired results. Users will be able to track their data using the platform, which is protected by a blockchain to preserve a customer's privacy.
What's Driving This Trend
- Personalized Skincare
- Disruptive innovation opportunity: Develop personalized skincare products and services based on consumers' epigenetic profiles.
- At-home Testing
- Disruptive innovation opportunity: Create at-home testing kits for consumers to measure and track the effectiveness of skincare products.
- Blockchain in Beauty
- Disruptive innovation opportunity: Implement blockchain technology to enhance privacy and security in the beauty industry.
Who This Affects Most
- Beauty and Skincare
- Disruptive innovation opportunity: Integrate epigenetic testing and personalized recommendations into the beauty and skincare industry.
- Health Tech
- Disruptive innovation opportunity: Develop health tech solutions that enable consumers to monitor and optimize their skincare routines.
- Blockchain Technology
- Disruptive innovation opportunity: Apply blockchain technology to improve privacy and data security in various industries, including beauty and skincare.
